Israel Englander’s Biomea Fusion BMEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-20,000
Closed -$77.6K 5877
2024
Q4
$77.6K Sell
20,000
-100,000
-83% -$797K ﹤0.01% 5520
2024
Q3
$1.21M Buy
120,000
+70,000
+140% +$455K ﹤0.01% 4116
2024
Q2
$225K Buy
50,000
+30,000
+150% +$305K ﹤0.01% 5074
2024
Q1
$299K Sell
20,000
-30,000
-60% -$494K ﹤0.01% 5144
2023
Q4
$726K Sell
50,000
-69,600
-58% -$846K ﹤0.01% 4398
2023
Q3
$1.65M Buy
119,600
+101,400
+557% +$1.83M ﹤0.01% 3743
2023
Q2
$399K Buy
+18,200
New +$570K ﹤0.01% 4699

Other funds holding BMEA

Israel Englander's BMEA Position: Q2 2026 in Review

Israel Englander sold out of Biomea Fusion (BMEA) in Q2 2026, closing a stake of 18,335 shares — an estimated $28.1K sold.

Israel Englander first reported a position in BMEA in Q4 2021 and held it in 16 quarters. The position peaked at $13.9M in Q3 2024. 61 funds tracked by Wall St. Rank hold BMEA as of Q2 2026.

  • Israel Englander reported no remaining Biomea Fusion position as of Q2 2026 after selling out during the quarter.
  • Israel Englander sold 18,335 Biomea Fusion shares in Q2 2026, an estimated $28.1K.
  • Israel Englander first reported a position in Biomea Fusion in Q4 2021 and held it in 16 quarters.
  • Israel Englander's Biomea Fusion position peaked at $13.9M in Q3 2024.
  • 61 funds tracked by Wall St. Rank held Biomea Fusion as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.